US Stock Futures Treasury Yields Fall After Reports of Putins Nuclear Doctrine Shift AMD Pledges 10 Billion Investment in Taiwans AI and Semiconductor Ecosystem Stellantis Turnaround Prediction Market Regulation Oura IPO Key Morning Market Developments BristolMyers Squibb Shares Rise on AI Partnership with Anthropic Analysts See Potential Upside Catalyst Portfolio Manager Trims Position After Stock Surges 80 Since April Citing Parabolic Move Caution Spotify Surges 13 on AI Music Deal with Universal Music and LongTerm Guidance PGY Q1 2026 Earnings Massive EPS Beat Shocks Analysts Stock Surges KOP Q1 2026 Earnings EPS Surges Past Estimates with 2972 Beat KEP Q4 2025 Earnings EPS Miss Weighs on Shares Amid Cost Pressures AEMD Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares Modestly Emerson Radio MSN Q1 2024 Earnings Narrow Loss Continues as Stock Gains on Operational Updates California Resources Corporation Q1 2026 Earnings EPS Beat Lifts Shares Amid Volatile Energy Markets NextNav Inc NN Gains 168 as Stock Tests Key Resistance Near 2283 TCW Strategic Income Fund Holds Steady at 451 as Investors Assess Support and Resistance Levels Rent the Runway RENT Treads Water at 386 Holding Above Support ServiceTitan TTAN Inches Higher Amid Consolidation Near Key Resistance Neptune Insurance Holdings NP Holds Steady Above Support Despite Thin Gains Bond Yields Likely to Remain Elevated Amid Geopolitical Uncertainty Market Signals Suggest Hut 8 Corp Q3 2024 Earnings Narrows Loss Expectancy with EPS Beat Federated Hermes FHI Gains 176 as Stock Tests Key Resistance Levels Prediction Markets Surge Among Young Male Demographics Industry Reaches MultiBillion Dollar Scale Salesforce Buyback Program May Mitigate Investor Concerns Amid Growth Reacceleration Hopes Japans Megabanks Post Record Profits Yet Analysts Flag Potential Headwinds BofA Increases Philip Morris International Price Target by 9 Cites Strong Outlook Eli Lillys NextGeneration Obesity Drug Retatrutide Clears Key Trial Exxons Carbon Capture Ambitions Face Backlash on Gulf Coast Immunic Appoints Erik Lundgren as CEO Amid Phase 3 Multiple Sclerosis Trial Progress